ECM
REGN icon

Evergreen Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Evergreen Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
17,761
+4,671
+36% +$3.18M 0.19% 116
2026
Q1 		$10.1M Buy
13,090
+6,889
+111% +$5.27M 0.22% 111
2025
Q4 		$4.79M Buy
6,201
+287
+5% +$195K 0.11% 190
2025
Q3 		$3.33M Sell
5,914
-2,220
-27% -$1.26M 0.08% 217
2025
Q2 		$4.27M Buy
8,134
+4,253
+110% +$2.37M 0.13% 175
2025
Q1 		$2.46M Buy
3,881
+16
+0.4% +$11K 0.08% 224
2024
Q4 		$2.75M Buy
3,865
+3,030
+363% +$2.54M 0.09% 210
2024
Q3 		$878K Sell
835
-2,860
-77% -$3.18M 0.03% 347
2024
Q2 		$3.88M Buy
3,695
+55
+2% +$53.3K 0.14% 168
2024
Q1 		$3.5M Sell
3,640
-1,291
-26% -$1.23M 0.13% 174
2023
Q4 		$4.33M Sell
4,931
-92
-2% -$75.8K 0.18% 151
2023
Q3 		$4.13M Sell
5,023
-2,091
-29% -$1.64M 0.18% 148
2023
Q2 		$5.11M Buy
7,114
+87
+1% +$67.1K 0.21% 132
2023
Q1 		$5.77M Sell
7,027
-25
-0.4% -$18.9K 0.26% 113
2022
Q4 		$5.09M Sell
7,052
-74
-1% -$54.6K 0.24% 123
2022
Q3 		$4.91M Sell
7,126
-118
-2% -$74.3K 0.26% 114
2022
Q2 		$4.28M Buy
7,244
+2,728
+60% +$1.77M 0.22% 124
2022
Q1 		$3.15M Buy
4,516
+66
+1% +$41.8K 0.13% 190
2021
Q4 		$2.81M Buy
4,450
+437
+11% +$269K 0.11% 199
2021
Q3 		$2.43M Sell
4,013
-1,324
-25% -$822K 0.11% 194
2021
Q2 		$2.98M Buy
5,337
+119
+2% +$60.3K 0.14% 161
2021
Q1 		$2.47M Buy
+5,218
New +$2.54M 0.13% 174

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Evergreen Capital Management's REGN Position: Q2 2026 in Review

Evergreen Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 36% in Q2 2026, buying an estimated $3.18M and bringing the position to 17,761 shares worth $11.1M. The position accounts for 0.19% of the portfolio, ranked #116.

Evergreen Capital Management first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Evergreen Capital Management held 17,761 shares of Regeneron Pharmaceuticals worth $11.1M as of Q2 2026.
  • Evergreen Capital Management bought 4,671 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.18M.
  • Regeneron Pharmaceuticals made up 0.19% of Evergreen Capital Management's portfolio in Q2 2026, its #116 holding.
  • Evergreen Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.